Results 151 to 160 of about 297,519 (217)

Strengthening public understanding and prevention of dengue in Malaysia: insights and recommendations based on knowledge, attitudes, and practices toward vector control and vaccination. [PDF]

Front Public Health
Shafie AA, Ismail Z, Yong K, Sibindi T, Foo S, Dapari R.   +5 more
europepmc   +1 more source

Targeting dengue through mucosal vaccination: the potential of NS1 and bacterial spore-based delivery platforms. [PDF]

Front Immunol
Zulkifli N, Shin OS, AbuBakar S.
europepmc   +1 more source

Cross-serotype immunity elicited by a consensus dengue NS1 mRNA vaccine in mice. [PDF]

PLoS One
Tharakhet K, Prompetchara E, Khawsang C, Saithong S, Kaewpang P, Yostrerat N, Wangsoontorn P, Sontikun J, Tantratorn S, Khotprathum T, Lam K, Heyes J, Weissman D, Ruxrungtham K, Ketloy C.   +14 more
europepmc   +1 more source

Unresolved questions in pediatric dengue: from disease mechanisms to prevention. [PDF]

Curr Opin Infect Dis
Lopez-Medina E.
europepmc   +1 more source

Travel vaccination in senior travelers: current evidence, challenges, and prevention. [PDF]

Trop Dis Travel Med Vaccines
Rossanese A, Tomasi A.
europepmc   +1 more source

Dengue vaccine: a hidden risk to Aedes aegypti control in Brazil. [PDF]

Osong Public Health Res Perspect
Golias HC.
europepmc   +1 more source

Therapeutic approaches against dengue virus: current status of vaccines, antivirals, and monoclonal antibodies. [PDF]

Emerg Microbes Infect
Bouzidi HS, De Lamballerie X, Touret F.
europepmc   +1 more source

COVID-19 Virus Infection and Transmission are Observably Less in Highly Dengue-endemic Countries: Can Dengue Vaccines be “Repurposed” to Prevent COVID-19?

, 2020
Biswas S, Sukla S.
europepmc   +1 more source

Introduction of the dengue vaccine in Brazil: the importance of a strengthened Unified Health System in confronting arboviruses. [PDF]

Rev Lat Am Enfermagem
Maciel ELN, Gadelha CAG, Fernandes EG, Percio J, Araújo ACM, Victer TNDF, Cunha RVD, Werneck GL, Lima NT.   +8 more
europepmc   +1 more source

Mapping immune responses to TAK-003 dengue vaccine: immunogenicity across the clinical development program. [PDF]

Front Immunol
Mandaric S, El Hindi T, Nascimento EJM, Saez-Llorens X, Borja-Tabora C, Friberg H, Tricou V, Roubinis N, Gottardo R, Currier JR, Sharma M, Biswal S.   +11 more
europepmc   +1 more source